BENEVIR BIOPHARM
BeneVir's immunotherapies for cancer are designed to induce the immune system to rid the body of two types of tumor cells: those currently responsible for cancer and those responsible for tumor recurrence and poor clinical outcomes. This is a unique approach in the emerging field of cancer immunotherapy.
BENEVIR BIOPHARM
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.benevirbiopharm.com
Total Employee:
1+
Status:
Active
Contact:
6465943703
Total Funding:
7 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Amazon Virginia Region
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
HelioWave Technologies
HelioWave Technologies is leveraging innovative microfluidic-based systems to revolutionize the way of sterility of biopharma products.
InCytu
InCytu develops anticancer immunotherapies that use the patient's own immune system to selectively target and destroy tumor cells.
Current Employees Featured
Ian Mohr Chair Of Scientific @ BeneVir Biopharm
Chair Of Scientific
Steven Fuhrmann VP of Research Operations @ BeneVir Biopharm
VP of Research Operations
2016-02-01
Founder
Official Site Inspections
http://www.benevirbiopharm.com
- Host name: ecbiz193.inmotionhosting.com
- IP address: 198.46.81.213
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
